DaBomb Protein Biotech Corp. (6578.TWO)

TWD 19.2

(-2.54%)

Market Cap (In TWD)

1.25 Billion

Revenue (In TWD)

384.41 Million

Net Income (In TWD)

-57.02 Million

Avg. Volume

722.03 Thousand

Currency
TWD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
18.0-33.9
PE
-
EPS
-
Beta Value
0.648
ISIN
TW0006578008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Ms. Yu Fen Liu
Employee Count
-
Website
https://www.dabombprotein.com
Ipo Date
2016-07-20
Details
DaBomb Protein Biotech Corp., a specialized biotech company, primarily engages in the development of antibiotics alternatives in animal health industry. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023. DaBomb Protein Biotech Corp. was founded in 2001 and is based in Tainan, Taiwan.